Can Nanotech or Bacteria Provide a Cure for Ebola?

AI Thread Summary
The discussion centers on the potential for genetically engineered bacteria or nanotechnology to target Ebola strains, questioning why effective cures have not yet emerged. Participants highlight that while there is ongoing research, developing treatments is complex and not as straightforward as it may seem. The conversation shifts to nanomedicine, which is still in its infancy regarding Ebola, with limited peer-reviewed studies available. Comparisons are drawn between Ebola and other viruses like polio and HIV, emphasizing that different viruses require distinct approaches due to their unique mechanisms of infection and reproduction. The high mutation rates of viruses complicate treatment development, necessitating strategies that target multiple viral processes. Some innovative therapies, such as interferon treatments, show promise in enhancing the immune response against various viruses, but their effectiveness in humans remains uncertain. Overall, while there are creative ideas for broad-spectrum antiviral therapies, many remain in the experimental stage and have yet to be commercialized.
Syed Ammar
Messages
25
Reaction score
1
I was just wondering if some bacteria or nanotechnology could be genetically engineered to target the Ebola strains? Is this possible?
If it is then why is no one coming up with a cure?
 
Biology news on Phys.org
Syed Ammar said:
If it is then why is no one coming up with a cure?

You can be sure they are hard at work. Trick is, it is never as easy as snapping your fingers.
 
Syed Ammar said:
I was just wondering if some bacteria or nanotechnology could be genetically engineered to target the Ebola strains? Is this possible?

How would that work? Are there existing treatments that use bacteria or nanotechnology to combat viruses?
 
Why is not the answer about curing Ebola EVD the same as for polio or HIV ( each of which has many more victims and a much longer time to develop a cure - which is not a vaccine )?
 
I guess others will give a more detailed answer, but basically there are many different viruses which use different techniques when attacking cells/reproducing, so what works against one, doesn't have to work against another.
 
Doug Huffman said:
Why is not the answer about curing Ebola EVD the same as for polio or HIV ( each of which has many more victims and a much longer time to develop a cure - which is not a vaccine )?
Not sure what you are saying there. There is no "cure" for polio or HIV.
Polio eradication is through administration of vaccine(s), so that the body prohibits the polio virus that enters the gut from infecting tissue.

HIV treatment is administration of a cocktail of drugs that keep the virus responsible for the disease in check.
 
What ALL viruses have in common is the lack of 'machinery' with which to reproduce. That said, there are only about a dozen virus families, of 5000-ish known, that sicken humans.

Borek said:
I guess others will give a more detailed answer, but basically there are many different viruses which use different techniques when attacking cells/reproducing, so what works against one, doesn't have to work against another.
 
Doug Huffman said:
What ALL viruses have in common is the lack of 'machinery' with which to reproduce. That said, there are only about a dozen virus families, of 5000-ish known, that sicken humans.

How is it related to what I wrote?
 
  • #10
Doug Huffman said:
What ALL viruses have in common is the lack of 'machinery' with which to reproduce.

Yes but that's not in of itself a target, there's no real difference between viral mRNA and human mRNA. Instead anti-virals have to target any number of processes that can be very different e.g. anti-retrovirals can target viral reverse transcriptase to prevent DNA formation. This will be useless against adenoviruses. Other targets include entry into the cell and viral genome incorporation amongst others, both of which differ for different species.

On top of this viruses mutate at an incredibly high rate making them annoyingly good at developing resistance. To get around this I believe anti-virals (like HIV medication) targets multiple different things at once.
 
  • #11
Ryan_m_b said:
Yes but that's not in of itself a target, there's no real difference between viral mRNA and human mRNA. Instead anti-virals have to target any number of processes that can be very different e.g. anti-retrovirals can target viral reverse transcriptase to prevent DNA formation. This will be useless against adenoviruses. Other targets include entry into the cell and viral genome incorporation amongst others, both of which differ for different species.

That said, there are some creative ideas for therapies that could act against a broader spectrum of viruses. A simple example is interferon treatment which can be helpful against a number of viruses because it helps boost the immune system's antiviral defenses. Some of these antiviral defenses detect viral infection by scanning for long segments of double-stranded RNA which often occur as intermediates in the replication of RNA viruses, but are mostly absent in uninfected cells. Researchers have engineered some of these proteins to create treatments that could potentially target a broad spectrum of RNA viruses (see this previous PF thread for further discussion). Of course, the paper I cite above is a simple proof-of-concept experiment, and it is still unclear whether the treatment would work in humans. Still, it is an intriguing idea.
 
  • #12
Ygggdrasil said:
That said, there are some creative ideas for therapies that could act against a broader spectrum of viruses. A simple example is interferon treatment which can be helpful against a number of viruses because it helps boost the immune system's antiviral defenses. Some of these antiviral defenses detect viral infection by scanning for long segments of double-stranded RNA which often occur as intermediates in the replication of RNA viruses, but are mostly absent in uninfected cells. Researchers have engineered some of these proteins to create treatments that could potentially target a broad spectrum of RNA viruses (see this previous PF thread for further discussion). Of course, the paper I cite above is a simple proof-of-concept experiment, and it is still unclear whether the treatment would work in humans. Still, it is an intriguing idea.

Quite true, though as promising as DRACOs are as far as I'm aware none have reached market yet.
 
  • #13
Borek said:
You can be sure they are hard at work. Trick is, it is never as easy as snapping your fingers.
Oh! Ok :(
 
Back
Top